MENU
LYRA Lyra Therapeutics Chart, History Price & Graph
a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
LYRA and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, LYRA has been closely correlated with GLYC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then GLYC could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To LYRA | 1D Price Change % | ||
|---|---|---|---|---|
| LYRA | 100% | -6.90% | ||
| GLYC - LYRA | 86% Closely correlated | -3.52% | ||
| EYPT - LYRA | 38% Loosely correlated | -8.88% | ||
| BCYC - LYRA | 27% Poorly correlated | -3.12% | ||
| RVMD - LYRA | 23% Poorly correlated | -2.51% | ||
| ALZN - LYRA | 23% Poorly correlated | +2.13% | ||
More | ||||
Groups containing LYRA
Correlation & Price change
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To LYRA | 1D Price Change % |
|---|---|---|
| LYRA | 100% | -6.90% |
| LYRA (2 stocks) | 98% Closely correlated | +2.12% |
| therapeutics (57 stocks) | 9% Poorly correlated | +20.54% |
| diseases (42 stocks) | 8% Poorly correlated | +1.03% |
| treatment (61 stocks) | 8% Poorly correlated | +0.91% |